You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Does treatment of depression in ageing populations decrease risk of mortality?
  1. Wayne J Katon
  1. Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, Washington, USA
  1. Correspondence to: Dr Wayne J Katon, Department of Psychiatry & Behavioral Sciences, University of Washington, 1959 NE Pacific Avenue, Campus Box 356560, Seattle, WA 98195-6560, USA; wkaton{at}uw.edu

https://doi.org/10.1136/eb-2013-101470

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Gallo JJ, Morales KH, Bogner HR, et al. Long-term effect of depression care management on mortality in older adults: follow-up of cluster randomised clinical trial in primary care. BMJ 2013;346:f2570.OpenUrlAbstract/FREE Full Text

    Context

    Multiple epidemiological studies have found that depression is a risk factor for mortality in ageing populations.1–⇓3 For instance, a recent meta-analysis found that comorbid depression increases the risk of all-cause mortality in patients with diabetes by about 50%.2 Systematic reviews have also found that comorbid depression increases the risk of mortality in patients with coronary artery disease by up to twofold.3 However, prior studies that enhanced the quality of treatment of depression and depressive outcomes in ageing populations or those with specific chronic illnesses, such as diabetes or heart disease, …

    View Full Text

    Footnotes

    • Competing interests None.